Voloridge Investment Management
IMGN

Voloridge Investment Management’s Immunogen Inc IMGN Stock Holding History

Voloridge Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,221,231
Closed -$95.5M – 1407
2023
Q4 		$95.5M Buy
3,221,231
+708,980
+28% +$14.1M 0.38% 64
2023
Q3 		$39.9M Buy
2,512,251
+481,296
+24% +$8M 0.2% 137
2023
Q2 		$38.3M Buy
+2,030,955
New +$24M 0.18% 157
2021
Q4 		– Sell
-200,876
Closed -$1.14M – 1907
2021
Q3 		$1.14M Sell
200,876
-57,230
-22% -$331K 0.01% 1242
2021
Q2 		$1.7M Buy
+258,106
New +$1.8M 0.01% 1051
2020
Q2 		– Sell
-124,775
Closed -$425K – 1570
2020
Q1 		$425K Buy
124,775
+52,250
+72% +$228K 0.01% 759
2019
Q4 		$370K Buy
72,525
+3,964
+6% +$13.5K 0.01% 878
2019
Q3 		$166K Buy
+68,561
New +$182K ﹤0.01% 1002
2019
Q2 		– Sell
-274,316
Closed -$743K – 1158
2019
Q1 		$743K Buy
+274,316
New +$1.19M 0.02% 563

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Voloridge Investment Management's IMGN Position: Q1 2024 in Review

Voloridge Investment Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 3,221,231 shares — an estimated $95.5M sold.

Voloridge Investment Management first reported a position in IMGN in Q1 2019 and held it in 9 quarters. The position peaked at $95.5M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Voloridge Investment Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 3,221,231 Immunogen Inc shares in Q1 2024, an estimated $95.5M.
  • Voloridge Investment Management first reported a position in Immunogen Inc in Q1 2019 and held it in 9 quarters.
  • Voloridge Investment Management's Immunogen Inc position peaked at $95.5M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Voloridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.